Det anbefales at administrere vaccinen subkutant hos patienter med thrombocytopeni eller blødningsforstyrrelser (se afsnit 4. 4.)
It is recommended that in patients with thrombocytopenia or bleeding disorders the vaccine be administered subcutaneously (see section 4.4.).